265 related articles for article (PubMed ID: 32057323)
1. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).
Rafii H; Frère C; Benzidia I; Crichi B; Andre T; Assenat E; Bournet B; Carpentier A; Connault J; Doucet L; Durant C; Emmerich J; Gris JC; Hij A; Le Hello C; Madelaine I; Messas E; Ndour A; Villiers S; Marjanovic Z; Ait Abdallah N; Yannoutsos A; Farge D
J Med Vasc; 2020 Feb; 45(1):28-40. PubMed ID: 32057323
[TBL] [Abstract][Full Text] [Related]
2. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Bounameaux H; Brenner B; Cajfinger F; Debourdeau P; Khorana AA; Pabinger I; Solymoss S; Douketis J; Kakkar A
Lancet Oncol; 2016 Oct; 17(10):e452-e466. PubMed ID: 27733271
[TBL] [Abstract][Full Text] [Related]
3. [New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application].
Benzidia I; Connault J; Solanilla A; Michon-Pasturel U; Jamelot M; Nguessan MK; Hij A; Le Maignan C; Farge D; Frère C;
J Med Vasc; 2017 Dec; 42(6):375-383. PubMed ID: 29203044
[TBL] [Abstract][Full Text] [Related]
4. Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer.
Soff GA
J Natl Compr Canc Netw; 2018 May; 16(5S):670-673. PubMed ID: 29784753
[TBL] [Abstract][Full Text] [Related]
5. Management of cancer-associated venous thromboembolism - a case-based practical approach.
Voigtlaender M; Langer F
Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients.
Song AB; Rosovsky RP; Connors JM; Al-Samkari H
Vasc Health Risk Manag; 2019; 15():175-186. PubMed ID: 31417269
[TBL] [Abstract][Full Text] [Related]
8. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
Ross JA; Miller MM; Rojas Hernandez CM
Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
[TBL] [Abstract][Full Text] [Related]
10. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
11. Unanswered questions in venous thromboembolism.
Weitz JI
Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
[TBL] [Abstract][Full Text] [Related]
12. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
13. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
Wharin C; Tagalakis V
Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
[TBL] [Abstract][Full Text] [Related]
14. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated venous thromboembolism: Burden, mechanisms, and management.
Ay C; Pabinger I; Cohen AT
Thromb Haemost; 2017 Jan; 117(2):219-230. PubMed ID: 27882374
[TBL] [Abstract][Full Text] [Related]
16. Chest physicians' knowledge of appropriate thromboprophylaxis: insights from the PROMOTE study.
Bikdeli B; Sharif-Kashani B; Raeissi S; Ehteshami-Afshar S; Behzadnia N; Masjedi MR
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):667-72. PubMed ID: 21986466
[TBL] [Abstract][Full Text] [Related]
17. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.
Streiff MB; Holmstrom B; Angelini D; Ashrani A; Bockenstedt PL; Chesney C; Fanikos J; Fenninger RB; Fogerty AE; Gao S; Goldhaber SZ; Gundabolu K; Hendrie P; Lee AI; Lee JT; Mann J; McMahon B; Millenson MM; Morton C; Ortel TL; Ozair S; Paschal R; Shattil S; Siddiqi T; Smock KJ; Soff G; Wang TF; Williams E; Zakarija A; Hammond L; Dwyer MA; Engh AM
J Natl Compr Canc Netw; 2018 Nov; 16(11):1289-1303. PubMed ID: 30442731
[TBL] [Abstract][Full Text] [Related]
18. Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot study.
Stepien K; Nowak K; Zalewski J; Pac A; Undas A
Vascul Pharmacol; 2019 Sep; 120():106567. PubMed ID: 31158568
[TBL] [Abstract][Full Text] [Related]
19. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
20. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial.
McBane Ii R; Loprinzi CL; Ashrani A; Perez-Botero J; Leon Ferre RA; Henkin S; Lenz CJ; Le-Rademacher JG; Wysokinski WE
Thromb Haemost; 2017 Oct; 117(10):1952-1961. PubMed ID: 28837207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
